Your browser doesn't support javascript.
loading
Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib.
Breccia, Massimo; Bartoletti, Daniela; Bonifacio, Massimiliano; Palumbo, Giuseppe A; Polverelli, Nicola; Abruzzese, Elisabetta; Bergamaschi, Micaela; Tieghi, Alessia; Tiribelli, Mario; Iurlo, Alessandra; Cavazzini, Francesco; Sgherza, Nicola; Binotto, Gianni; Isidori, Alessandro; D'Adda, Mariella; Crugnola, Monica; Bosi, Costanza; Heidel, Florian; Molica, Matteo; Scaffidi, Luigi; Cattaneo, Daniele; Latagliata, Roberto; Auteri, Giuseppe; Lemoli, Roberto M; Fanin, Renato; Russo, Domenico; Aversa, Franco; Cuneo, Antonio; Semenzato, Gianpietro; Catani, Lucia; Cavo, Michele; Vianelli, Nicola; Foà, Robin; Palandri, Francesca.
Afiliação
  • Breccia M; Division of Cellular Biotechnologies and Hematology, University Sapienza, Via Benevento 6, 00161, Rome, Italy. breccia@bce.uniroma1.it.
  • Bartoletti D; Institute of Hematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
  • Bonifacio M; Department of Hematology, University of Verona, Verona, Italy.
  • Palumbo GA; Division of Hematology, AOU "Policlinico-V. Emanuele", University of Catania, Catania, Italy.
  • Polverelli N; Unit of Blood Diseases and Stem Cells Transplantation, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy.
  • Abruzzese E; Division of Hematology, Ospedale S. Eugenio, Rome, Italy.
  • Bergamaschi M; Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS AOU San Martino-IST, Genoa, Italy.
  • Tieghi A; Division of Hematology, Azienda Ospedaliera-IRCSS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy.
  • Tiribelli M; Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy.
  • Iurlo A; Hematology Division, IRCCS Ca' Granda - Maggiore Policlinico Hospital Foundation, University of Milan, Milan, Italy.
  • Cavazzini F; Division of Hematology, University of Ferrara, Ferrara, Italy.
  • Sgherza N; Division of Hematology, Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy.
  • Binotto G; Unit of Hematology and Clinical Immunology, University of Padova, Padua, Italy.
  • Isidori A; Hematology and Stem Cell Transplant Center, AORMN Hospital, Pesaro, Italy.
  • D'Adda M; Division of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy.
  • Crugnola M; Division of Hematology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Bosi C; Division of Hematology, Piacenza, Italy.
  • Heidel F; Internal Medicine II, Hematology and Oncology, Friedrich-Schiller-University Medical Center, Jena, Germany.
  • Molica M; Division of Cellular Biotechnologies and Hematology, University Sapienza, Via Benevento 6, 00161, Rome, Italy.
  • Scaffidi L; Department of Hematology, University of Verona, Verona, Italy.
  • Cattaneo D; Hematology Division, IRCCS Ca' Granda - Maggiore Policlinico Hospital Foundation, University of Milan, Milan, Italy.
  • Latagliata R; Division of Cellular Biotechnologies and Hematology, University Sapienza, Via Benevento 6, 00161, Rome, Italy.
  • Auteri G; Institute of Hematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
  • Lemoli RM; Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS AOU San Martino-IST, Genoa, Italy.
  • Fanin R; Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy.
  • Russo D; Unit of Blood Diseases and Stem Cells Transplantation, Department of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy.
  • Aversa F; Division of Hematology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
  • Cuneo A; Division of Hematology, University of Ferrara, Ferrara, Italy.
  • Semenzato G; Unit of Hematology and Clinical Immunology, University of Padova, Padua, Italy.
  • Catani L; Institute of Hematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
  • Cavo M; Institute of Hematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
  • Vianelli N; Institute of Hematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
  • Foà R; Division of Cellular Biotechnologies and Hematology, University Sapienza, Via Benevento 6, 00161, Rome, Italy.
  • Palandri F; Institute of Hematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
Ann Hematol ; 98(4): 889-896, 2019 Apr.
Article em En | MEDLINE | ID: mdl-30515542
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Índice de Massa Corporal / Mielofibrose Primária Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Índice de Massa Corporal / Mielofibrose Primária Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália